Pushing Back on High Drug Prices.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Abstract:
      The article discusses pushback from public to regulate higher cost of prescription drugs by drug manufacturers by citing reference of rising cost of the EpiPen, an epinephrine autoinjector, from Mylan and views of Peter B. Bach, director at Memorial Sloan Kettering Cancer Center, on it.